¼¼°èÀÇ ÇコÄɾî BPO ½ÃÀå : »ý¸í°úÇÐ ¼­ºñ½ºº°, ÆäÀÌ¾î ¼­ºñ½ºº°, ÇÁ·Î¹ÙÀÌ´õ ¼­ºñ½ºº°, Áö¿ªº° ¿¹Ãø(-2029³â)
Healthcare BPO Market by Outsourcing Models, Provider, Payer, Life Science (R&D, Manufacturing, Sales & Marketing ), & Region - Global Forecast to 2029
»óǰÄÚµå : 1499313
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 369 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,621,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,792,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è °Ç°­ °ü¸® BPO ½ÃÀå ±Ô¸ð´Â 2024³â 3,953¾ï ´Þ·¯¿¡¼­ 2029³â 6,266¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024³âºÎÅÍ 2029³â±îÁöÀÇ CAGRÀº 9.7%°¡ µÉ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

ÇコÄɾî BPO ½ÃÀåÀÇ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â °ÍÀº »ó½ÂÇÏ´Â ÀÇ·áºñ »è°¨ ¾Ð·Â »ó½Â, Á¦¾à¡¤¹ÙÀÌ¿À ÀǾàǰ ¾÷°è¿¡ À־ÀÇ ¾Æ¿ô¼Ò½Ì °æÇâÀÇ »ó½ÂÀÔ´Ï´Ù. °í±Þ µ¥ÀÌÅÍ ºÐ¼®°ú ÀΰøÁö´É ±â¹Ý â¾à µµ±¸ÀÇ Ã¤¿ë Áõ°¡¿Í °°Àº ¿äÀÎÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå È®´ë¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ¸ÞµðÄÉÀÌµå ¼­ºñ½ºÀÇ µ¥ÀÌÅÍ ¼öÁý ÇÁ·Î¼¼½º¿¡´Â ÇѰ谡 ÀÖÀ¸¸ç ½ÃÀå ¼ºÀå¿¡ ¾î·Á¿òÀÌ ÀÖ½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó³âµµ 2022-2029³â
±âÁسâ 2023³â
¿¹Ãø ±â°£ 2024-2029³â
°ËÅä ´ÜÀ§ ±Ý¾×(10¾ï ´Þ·¯)
ºÎ¹®º° »ý¸í°úÇÐ ¼­ºñ½ºº°, ÆäÀÌ¾î ¼­ºñ½ºº°, ÇÁ·Î¹ÙÀÌ´õ ¼­ºñ½ºº°, Áö¿ªº°
´ë»ó Áö¿ª ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿, ¾ÆÇÁ¸®Ä« ¹× GCC ±¹°¡

ÆäÀÌ¾î ¼­ºñ½ºº°·Î, ÀÌ ºÎ¹®Àº º¸Çè±Ý û±¸ °ü¸® ¼­ºñ½º, ÅëÇÕ ÇÁ·ÐÆ®¿£µå ¼­ºñ½º ¹× ¹é ¿ÀÇǽº ¾÷¹«, ȸ¿ø °ü¸® ¼­ºñ½º, »óǰ °³¹ß¡¤»ç¾÷ ȹµæ ¼­ºñ½º(PDBA), ÇÁ·Î¹ÙÀÌ´õ °ü¸® ¼­ºñ½º, ÄÉ¾î °ü¸® ¼­ºñ½º, û±¸¡¤È¸°è °ü¸® ¼­ºñ½º, ÀÎ»ç ¼­ºñ½º·Î ³ª´­ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Áß ÅëÇÕ ÇÁ·ÐÆ®¿£µå ¼­ºñ½º¿Í ¹é¿ÀÇǽº ¾÷¹«´Â ÇコÄɾî BPO ½ÃÀå¿¡¼­ 2À§ÀÇ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â ÇコÄɾî ÁöºÒÀÚÀÇ ¾÷¹« È¿À²À» ÃÖÀûÈ­Çϴµ¥ À־ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¸ÞÀÏ ·ë ¼­ºñ½º, µ¥ÀÌÅÍ ½ºÅ©·¯ºù, 24½Ã°£ ÄÁÅà ¼¾ÅÍ Áö¿ø µîÀÇ ¾÷¹«¸¦ ¾Æ¿ô¼Ò½ÌÇÔÀ¸·Î½á, ÁöºÒÀÚ´Â ¼­ºñ½º ǰÁúÀ» Çâ»ó½ÃŰ¸é¼­ ¿î¿µ ºñ¿ëÀ» ´ëÆø Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àû ¾Æ¿ô¼Ò½ÌÀ» ÅëÇØ ÆäÀÌÆÛ´Â ÀÚ»çÀÇ ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÏ°í ¾÷¹«¸¦ È¿À²È­Çϰí Àü¹ÝÀûÀÎ ¼º°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ 24½Ã°£ ´ëÀÀ¿¡ ´ëÇÑ ¿ä±¸ µî °í°´ÀÇ ±â´ë Áõ°¡°¡ ÀÌ·¯ÇÑ ¾÷¹«ÀÇ ¾Æ¿ô¼Ò½ÌÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áß¿äÇÑ ¾÷¹«¸¦ Àü¹® BPO Á¦°ø¾÷ü¿¡ À§Å¹ÇÔÀ¸·Î½á, ÁöºÒÀÚ´Â ½Å¼ÓÇÑ ºÒ¸¸À̳ª ¹®ÀÇ ÇØ°á, È¿À²ÀûÀÎ °í°´°ü°è °ü¸®, ¿øÈ°ÇÑ ¼­ºñ½º Á¦°øÀ» ½ÇÇöÇÒ ¼ö ÀÖ¾î ÇコÄɾî BPO Àü¸Á¿¡¼­ ÇÁ·ÐÆ® ¿£µå ¼­ºñ½º¿Í ¹é¿ÀÇǽº ¾÷¹«ÀÇ ÅëÇÕÀÌ Áß¿äÇÑ À§Ä¡¸¦ Â÷ÁöÇÏ°Ô µÇ¾ú½À´Ï´Ù.

»ý¸í°úÇм­ºñ½º ºÐ¾ß¿¡¼­ ÇコÄɾî BPO ½ÃÀåÀº Á¦Á¶, ¿¬±¸°³¹ß, ºñÀÓ»ó ¼­ºñ½º·Î ±¸ºÐµË´Ï´Ù. ºñÀÓ»ó ¼­ºñ½º ºÐ¾ß´Â ¶ÇÇÑ ¿µ¾÷ ¹× ¸¶ÄÉÆÃ ¼­ºñ½º, °ø±Þ¸Á °ü¸® ¹× ¹°·ù ¼­ºñ½º ¹× ±âŸ ºñÀÓ»ó ¼­ºñ½º·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß ÆÇ¸Å ¹× ¸¶ÄÉÆÃ ¼­ºñ½º ºÐ¾ß´Â ÇコÄɾî BPO ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾî BPO ½ÃÀåÀÇ ºñÀÓ»ó ¼­ºñ½º ºÐ¾ß¿¡¼­ ¿µ¾÷ ¹× ¸¶ÄÉÆÃ ¼­ºñ½º°¡ ¿ìÀ§¸¦ Â÷ÁöÇϰí ÀÖ´Â °ÍÀº ÁÖ·Î Á¦¾à ¾÷°èÀÇ º¹ÀâÇÑ ±ÔÁ¦ »óȲ¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦°¡ ²÷ÀÓ¾øÀÌ ÁøÈ­ÇÏ´Â °¡¿îµ¥, Á¦¾à±â¾÷Àº ¿¬±¸°³¹ßÀ̳ª »ý»ê°ú °°Àº ÇÙ½ÉÀûÀΠȰµ¿¿¡ ÀÚ¿øÀ» ÇÒ´çÇÒ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ±× °á°ú º¹ÀâÇÑ ±ÔÁ¦ ȯ°æÀ» È¿°úÀûÀ¸·Î ±Øº¹Çϱâ À§ÇÑ Àü¹® ¸¶ÄÉÆÃ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ë±Ô¸ð ÇöÀå ºÎ´ëÀÇ Çʿ伺ÀÌ Á¦¾à ¾÷°è¿¡¼­ ÆÇ¸Å °è¾à Á¶Á÷ÀÇ ÃâÇö¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¶Á÷Àº Á¦¾à ȸ»ç°¡ ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ÇÑÆí, Á¦¾à ȸ»çÀÇ ¸¶ÄÉÆÃ ³ë·ÂÀ» °­È­ÇÏ°í ¸ÂÃãÇü ÆÇ¸Å ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ±× °á°ú, ¿µ¾÷¡¤¸¶ÄÉÆÃ ºÎ¹®Àº ÇコÄɾî BPO ½ÃÀåÀÇ ºñÀÓ»ó ¼­ºñ½º ºÎ¹®¿¡¼­ ÃÖ´ëÀÇ Á¡À¯À²À» ȹµæÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¦¾à ±â¾÷ÀÇ ±ÔÁ¦ Áؼö¸¦ ÃËÁøÇÏ°í ½ÃÀå¿¡¼­ÀÇ Á¸Àç°¨À» ³ôÀ̴µ¥ À־ ÇʼöÀûÀÎ ¿ªÇÒ ¸¦ ´ã´çÇÏ´Â °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ÇコÄɾî BPO ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, »ý¸í°úÇÐ ¼­ºñ½ºº°, ÆäÀÌ¾î ¼­ºñ½ºº°, ÇÁ·Î¹ÙÀÌ´õ ¼­ºñ½ºº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Áß¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ÇコÄɾî BPO ½ÃÀå, »ý¸í°úÇÐ ¼­ºñ½ºº°

Á¦7Àå ÇコÄɾî BPO ½ÃÀå, ÆäÀÌ¾î ¼­ºñ½ºº°

Á¦8Àå ÇコÄɾî BPO ½ÃÀå, ÇÁ·Î¹ÙÀÌ´õ ¼­ºñ½ºº°

Á¦9Àå ÇコÄɾî BPO ½ÃÀå, Áö¿ªº°

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦12Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global healthcare BPO market is projected to reach USD 626.6 billion by 2029 from USD 395.3 billion in 2024, at a CAGR of 9.7% from 2024 to 2029. The growth of the healthcare BPO market is being driven by increased pressure to reduce rising healthcare costs and the growing trend of outsourcing in the pharmaceutical and biopharmaceutical industries. Factors such as advanced data analytics and the increasing adoption of artificial intelligence-based tools for drug discovery are presenting lucrative opportunities for market expansion in the forecast period. However, limitations in the data capturing process in Medicaid services pose challenges to the market's growth.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy Provider service, Payer service, and Life Science service
Regions coveredAsia Pacific, North America, Europe, Latin America, and the Middle East and Africa and GCC countries

"The integrated front-office services and back-office operations segment is estimated to account for the second-largest share in Healthcare BPO market.''

Based on payer services, the segment is divided into claims management services, integrated front-end services and back-office operations, member management services, product development & business acquisition services (PDBA), provider management services, care management services, care management services, billing and accounts management services and HR services. Among these, integrated front-end services and back-office operations is estimated to account for the second-largest share in the healthcare BPO market. This is due to their pivotal role in optimizing operational efficiency for healthcare payers. By outsourcing tasks like mailroom services, data scrubbing, and round-the-clock contact center support, payers can significantly reduce operational costs while enhancing service quality. This strategic outsourcing allows payers to focus on their core competencies, streamlining their operations and improving overall business performance. Furthermore, the rising expectations of customers, including the demand for 24-hour service availability, are driving the need for outsourcing these functions. By entrusting these critical tasks to specialized BPO providers, payers can ensure prompt complaint and query resolutions, efficient customer relationship management, and seamless service delivery, thus solidifying the prominence of integrated front-end services and back-office operations in the healthcare BPO landscape.

"Sales and marketing service segment accounts for the largest share in healthcare BPO market during the forecast period by non-clinical services."

Based on life science services segment, the healthcare BPO market is segmented into manufacturing, research and development, and non-clinical services. The non-clinical service segment is further divided into sales & marketing services, Supply chain management & logistics services, and other non-clinical services. Among these the sales and marketing services segment accounts for the largest share in healthcare BPO market. The dominance of sales and marketing services in the non-clinical services segment of the healthcare BPO market is primarily attributed to the intricate regulatory landscape within the pharmaceutical industry. With regulations constantly evolving, pharmaceutical companies are compelled to allocate their resources towards core activities such as research and development, and production. Consequently, this has intensified the demand for specialized marketing services to navigate the complex regulatory environment effectively. Moreover, the necessity for extensive field forces has spurred the emergence of contract sales organizations in the pharmaceutical sector. These organizations offer tailored sales solutions, augmenting the marketing efforts of pharmaceutical companies while allowing them to focus on their core competencies. As a result, the sales and marketing segment has garnered the largest share in the non-clinical services segment of the healthcare BPO market, reflecting the indispensable role it plays in facilitating pharmaceutical companies' compliance with regulations and enhancing their market presence.

"US holds the second largest segment in healthcare BPO market by destination geography during the forecast period."

In this report, the healthcare BPO market is segmented into source geography and destination geography. The source geography is divided into North America, Europe, and rest of the world, but the destination geography is further divided into India, US, Bulgaria and other EU countries, Philippines, China, Brazil, Kingdom of Saudi Arabia, and rest of the world. Among the destination geography segment, US holds the second largest position in the healthcare BPO market. This is due to a surge in the adoption of computer-assisted Revenue Cycle Management (RCM) coding systems. This uptick in RCM adoption among healthcare providers is primarily driven by the imperative to enhance operational efficiency, reduce costs, and minimize errors. As healthcare organizations increasingly recognize the benefits of leveraging advanced technology for streamlining their revenue cycles, the demand for outsourcing services in the US has correspondingly expanded. Outsourcing providers located in the US are strategically positioned to cater to this growing demand, offering specialized expertise in RCM optimization and leveraging their proximity to clients to provide tailored solutions. Additionally, the intricate and evolving regulatory landscape in the US healthcare sector necessitates a nuanced understanding of compliance requirements, further bolstering the demand for outsourcing services from domestic providers. Thus, the combination of technological advancements, cost-effectiveness, and regulatory complexities propels the United States to maintain its substantial presence as the second-largest destination for healthcare BPO services.

Breakdown of supply-side primary interviews, by company type, designation, and region:

List of Companies Profiled in the Report

Research Coverage

This report studies the healthcare BPO market based on product, procedure, technology, application, end user and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total healthcare BPO market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report

This report also includes.

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE

7 HEALTHCARE BPO MARKET, BY PAYER SERVICE

8 HEALTHCARE BPO MARKET, BY PROVIDER SERVICE

9 HEALTHCARE BPO MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â